» Articles » PMID: 23199544

Periodontal Therapy -- an Adjuvant for Glycemic Control

Overview
Specialty Endocrinology
Date 2012 Dec 4
PMID 23199544
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Periodontitis is an oral infection affecting the tooth- supporting tissues. Although the prime etiology for this condition is bacterial plaque, the host immune response also has substantial contribution to the destruction of the periodontal apparatus. Periodontitis elicits a "low grade systemic inflammation". Diabetes mellitus is intricately related to the development, progression and severity of periodontitis. The literature is abundant with studies depicting this association. Periodontal therapy (PT) involves removal of bacterial component leading to the resolution of clinical signs and symptoms of disease. This review aims to create awareness amongst the medical professionals regarding the two-way relationship between diabetes and periodontitis, emphasizing on the positive effects of PT.

Material And Methods: Studies addressing the effects of PT on glycemic control in type 2 Diabetes (T2DM) subjects were identified using PubMed search with key search terms such as "Glycemic control", "Periodontitis", "Periodontal therapy", "Type 2 diabetes mellitus". The review has been prepared by screening PUBMED database from January 1990 to March 2012.

Results: PT bears an unexplored potential and can serve as an adjuvant to the conventional treatment for diabetes.

Conclusion: A major conclusion of this review is that PT instituted in type 2 diabetic human subjects assists in amelioration of the inflammatory biomarker levels and glycemic status. There is a wide scope for further studies to highlight the beneficial effects of PT in diabetic subjects and the dire need for periodontal screening of these individuals for glycemic maintenance.

Citing Articles

Reducing Hemoglobin A1C Levels in Type II Diabetes: A Retrospective Analysis of the Renew Procedure.

Cross A, Balanoff W, Karl M, Schayes B Cureus. 2023; 15(10):e48039.

PMID: 37916232 PMC: 10617566. DOI: 10.7759/cureus.48039.


Periodontal Clinicoradiographic Status and Whole Saliva Soluble Urokinase Plasminogen Activation Receptor and Tumor Necrosis Factor Alpha Levels in Type-2 Diabetic and Non-diabetic Individuals.

Ali D, Qasem S, Baskaradoss J Oral Health Prev Dent. 2021; 19:481-488.

PMID: 34585873 PMC: 11640750. DOI: 10.3290/j.ohpd.b2082019.


Effects of oral health instructions on glycemic control and oral health status of periodontitis patients with type 2 diabetes mellitus: A preliminary observation.

Toda K, Mizutani K, Minami I, Ye M, Arakawa T, Mitsubayashi K J Dent Sci. 2019; 14(2):171-177.

PMID: 31210891 PMC: 6562110. DOI: 10.1016/j.jds.2019.01.009.


Management of diabolical diabetes mellitus and periodontitis nexus: Are we doing enough?.

Gurav A World J Diabetes. 2016; 7(4):50-66.

PMID: 26962409 PMC: 4766246. DOI: 10.4239/wjd.v7.i4.50.


Effect of non-surgical periodontal treatment on glycemic control of patients with diabetes: a meta-analysis of randomized controlled trials.

Li Q, Hao S, Fang J, Xie J, Kong X, Yang J Trials. 2015; 16:291.

PMID: 26137892 PMC: 4490675. DOI: 10.1186/s13063-015-0810-2.